A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
Public ClinicalTrials.gov record NCT02797951. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b Multicenter, Single-Arm, Open-Label Safety Study of LY2951742 (Galcanezumab) in Patients With Episodic or Chronic Cluster Headache
Study identification
- NCT ID
- NCT02797951
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 165 participants
Conditions and interventions
Interventions
- Galcanezumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 12, 2016
- Primary completion
- Jan 20, 2021
- Completion
- Jan 20, 2021
- Last update posted
- Feb 9, 2022
2016 – 2021
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Hospital | Phoenix | Arizona | 85054 | — |
| Stanford University Hospital | Palo Alto | California | 94304 | — |
| California Medical Clinic for Headache | Santa Monica | California | 90404 | — |
| Colorado Neurological Institute | Englewood | Colorado | 80113 | — |
| New England Institute for Clinical Research | Stamford | Connecticut | 06905 | — |
| University of South Florida | Tampa | Florida | 33612 | — |
| Atlanta Center of Medical Research | Atlanta | Georgia | 30331 | — |
| Michigan Head, Pain and Neurological Institute | Ann Arbor | Michigan | 48104 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Clinical Trials of South Carolina | Charleston | South Carolina | 29406 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007-4209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02797951, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 9, 2022 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02797951 live on ClinicalTrials.gov.